|
(ÁÖ)½ºÅ¸¸Þµå |
ÀÇ·á±â±â Á¦Á¶¾÷ü ½ÅÀÔ/°æ·Â ¸ðÁý °ø°í
°æ±â °í¾ç½Ã Àϻ걸 | ´ëÇÐ(4³â) Á¹¾÷ |
¼ö½Ãä¿ë |
5³â¡è |
ä¿ë½Ã |
11.26 |
|
|
³ªÀ̺¤ |
°¢ ºÐ¾ß ½ÅÀÔ ¹× °æ·Â»ç¿ø Á¤±ÔÁ÷ ¸ðÁý
Àü±¹ ÀüÁö¿ª | °íµîÇб³ |
»ó¹Ý±â »ç¿ø¸ðÁý |
°æ·Â¹«°ü |
ä¿ë½Ã |
12.11 |
|
|
(ÁÖ)¸¶Å©·ÎÁ¨ |
µ¥ÀÌÅͺм® ºÎ¹® ä¿ë (º´¿ªÆ¯·Ê °¡´É)
¼¿ï °³²±¸, ¼¿ï ±Ýõ±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
»ó¹Ý±â »ç¿ø¸ðÁý |
°æ·Â¹«°ü |
ä¿ë½Ã |
05.31 |
|
|
(ÁÖ)À¯´Ï¸Þµñ½º |
(ÁÖ)À¯´Ï¸Þµñ½º ÀÇ·á±â±â AS ä¿ëÇÕ´Ï´Ù
¼¿ï °³²±¸ | ´ëÇÐ(4³â) ÀçÇÐ |
¼ö½Ãä¿ë |
3³â¡è |
ä¿ë½Ã |
07.23 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
Omnichannel Engagement Lead
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
»ó¹Ý±â »ç¿ø¸ðÁý |
5³â¡è |
ä¿ë½Ã |
04.06 |
|
|
(ÁÖ)ÇÁ·ÎÅ彺 |
2023³â »ó¹Ý±â °¢ ºÎ¹® ½ÅÀÔ/°æ·Â ä¿ë
°æ±â ȼº½Ã | Çз¹«°ü |
°ø°³Ã¤¿ë |
°æ·Â¹«°ü |
ä¿ë½Ã |
01.20 |
|
|
½á¸ðÇǼŻçÀ̾ðƼÇÈ ÄÚ¸®¾Æ |
Compliance Specialist, Á¦Ç° ±ÔÁ¤°ü¸® ´ã´çÀÚ (¼®»ç½ÅÀÔ°¡
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
»ó¹Ý±â »ç¿ø¸ðÁý |
°æ·Â¹«°ü |
ä¿ë½Ã |
04.11 |
|
|
¹ÙÀÌ¿À´Ï¾Æ |
»ó¹Ý±â ¿µ¾÷/¸¶ÄÉÆÃ/Çмú ºÎ¹® ä¿ë
´ëÀü ´ë´ö±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
»ó¹Ý±â »ç¿ø¸ðÁý |
°æ·Â¹«°ü |
ä¿ë½Ã |
05.20 |
|
|
SGBIOCHEM |
[¿ø·áÀǾàÇ°, °Ç°½ÄÇ°] °¢ºÎ¹® °æ·Â ä¿ë[RA, ±¸¸Å, ¿µ¾÷]
°æ±â ¾È¾ç½Ã µ¿¾È±¸ | Çз¹«°ü |
¼ö½Ãä¿ë |
°æ·Â¹«°ü |
ä¿ë½Ã |
06.16 |
|
|
Çʸ³½º ÄÚ¸®¾Æ |
Philips Korea-Regulatory Affairs Country Lead-South Kore
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¼ö½Ãä¿ë |
10³â¡è |
ä¿ë½Ã |
11.10 |
|
|
(ÁÖ)À¯Á¤¾ÆÀÌÅØ |
2021³â (ÁÖ)À¯Á¤¾ÆÀÌÅØ ÇϹݱ⠰ø°³Ã¤¿ë
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
°ø°³Ã¤¿ë |
°æ·Â¹«°ü |
ä¿ë½Ã |
11.16 |
|
|
¹ÙÀÌ¿À¼Ö·ç¼Ç |
(ÁÖ)¹ÙÀÌ¿À¼Ö·ç¼Ç ¹ÙÀÌ¿ÀÀ¶ÇÕ¼ÒÀç»ç¾÷ºÎ Çмú¸¶ÄÉÆà Á÷¿ø ä
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
°ø°³Ã¤¿ë |
°æ·Â¹«°ü |
ä¿ë½Ã |
11.28 |
|
|
anssen |
[Janssen] Project Manager (Local Trial Manager)
¼¿ï ¿ë»ê±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
»ó¹Ý±â »ç¿ø¸ðÁý |
2³â¡è |
ä¿ë½Ã |
01.31 |
|
|
µ§Ã÷ÇöóÀ̽÷γªÄÚ¸®¾Æ |
[¿Ü±¹°è ÀÇ·á±â±â] RA Specialist
¼¿ï ¼ÛÆı¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¼ö½Ãä¿ë |
3³â¡è |
ä¿ë½Ã |
10.10 |
|
|
sbi |
ৡ༻ÆÄ°ßÁ÷ ¹Ø ¿Ü±ÙÁ÷ »ç¿ø ±Þ±¸ÇÕ´Ï´Ù ༺
Àü±¹ ÀüÁö¿ª | Çз¹«°ü |
¼ö½Ãä¿ë |
°æ·Â¹«°ü |
»ó½Ãä¿ë |
03.03 |
|